Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1851910rdf:typepubmed:Citationlld:pubmed
pubmed-article:1851910lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:1851910lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:1851910lifeskim:mentionsumls-concept:C1518997lld:lifeskim
pubmed-article:1851910lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:1851910lifeskim:mentionsumls-concept:C0259931lld:lifeskim
pubmed-article:1851910lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:1851910pubmed:issue3lld:pubmed
pubmed-article:1851910pubmed:dateCreated1991-6-25lld:pubmed
pubmed-article:1851910pubmed:abstractTextThe presence of antibodies (Abs) against hepatitis C virus (HCV) was analyzed in 26 haemophiliac patients; a prevalence of 38% was found in the total series and 56% in the treated patients. There were no cases with a positive serology among the three patients who had only received pasteurized factor. The frequency of detection of anti-HCV was higher in the patients who had a positive serology for HIV (67%) and hepatitis B virus (56%) than in the seronegative patients (24 and 29%, respectively). The patients with HCV Abs showed a decrease in the helper (CD4+) lymphocytic population, mainly due to the decrease in the helper inducer (CD4+/Leu8-) cells, such alterations being more evident in the patients who also were HIV+ who showed as well an increase in the T-cell activated lymphocytes (CD3+/la+) and a decrease in CD16+ natural killer cells. These results suggest that the lymphocytic alterations found in the patients with anti-HCV Abs are not specific and would rather be related to the presence or not of HIV infection.lld:pubmed
pubmed-article:1851910pubmed:languagespalld:pubmed
pubmed-article:1851910pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851910pubmed:citationSubsetIMlld:pubmed
pubmed-article:1851910pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1851910pubmed:statusMEDLINElld:pubmed
pubmed-article:1851910pubmed:monthJanlld:pubmed
pubmed-article:1851910pubmed:issn0025-7753lld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:GómezEElld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:GonzálezMMlld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:López...lld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:VicenteVVlld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:AlbercaIIlld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:MartínA MAMlld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:CorderoMMlld:pubmed
pubmed-article:1851910pubmed:authorpubmed-author:CorralMMlld:pubmed
pubmed-article:1851910pubmed:issnTypePrintlld:pubmed
pubmed-article:1851910pubmed:day26lld:pubmed
pubmed-article:1851910pubmed:volume96lld:pubmed
pubmed-article:1851910pubmed:ownerNLMlld:pubmed
pubmed-article:1851910pubmed:authorsCompleteYlld:pubmed
pubmed-article:1851910pubmed:pagination81-4lld:pubmed
pubmed-article:1851910pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:meshHeadingpubmed-meshheading:1851910-...lld:pubmed
pubmed-article:1851910pubmed:year1991lld:pubmed
pubmed-article:1851910pubmed:articleTitle[Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations].lld:pubmed
pubmed-article:1851910pubmed:affiliationServicio de Hematología, Hospital Clínico, Salamanca.lld:pubmed
pubmed-article:1851910pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1851910pubmed:publicationTypeEnglish Abstractlld:pubmed